Skip to content
Biodatica
Start free

Quarry Glue Holding Co LLC

NEW HAVEN, CT · also filed as None

Oncologygene editingFormed
Compare Sign in to watch

What changed

NIH R01 · $0.8M · Transcriptional Networks Controlling Erythroid Differentiation

3mo agoGrant renewalMar 23, 2026Source filing (opens the source filing in a new tab)

Momentum

68no change

Momentum 68 out of 100, unchanged since the last recompute.

Some recent activity, at a steady rate.

Runway (estimate)

~106months

The last disclosed raise still models out past a year.

Stage

Formed

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

21 pre-ticker oncology companies at Formed

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Grant

    R01 · $863k · non-dilutive

    Feb 1, 2026

    CHILDREN'S HOSP OF PHILADELPHIA · PI BLOBEL, GERD A · NHGRI · award ends Jan 31, 2030 · 3D Chromatin architectural dynamics at ultra-high resolution

    NIH RePORTER · NIH RePORTER 11205086 (opens the source filing in a new tab)

  2. Filing

    Form D · $20M

    Nov 18, 2025

    Quarry Glue Holding Co LLC · private raise, self-reported by the issuer

    SEC EDGAR · 0002096610-25-000001 (opens the source filing in a new tab)

  3. Grant

    R01 · $730k · non-dilutive

    Jan 1, 2025

    YALE UNIVERSITY · PI CREWS, CRAIG M · NHLBI · award ends Nov 30, 2028 · Targeted protein degraders for the treatment of b-hemoglobinopathies

    NIH RePORTER · NIH RePORTER 11252565 (opens the source filing in a new tab)

  4. Grant

    R01 · $670k · non-dilutive

    Aug 5, 2013

    CHILDREN'S HOSP OF PHILADELPHIA · PI BLOBEL, GERD A · NHLBI · award ends Jan 31, 2027 · Regulation of Hemoglobin Switching

    NIH RePORTER · NIH RePORTER 11293396 (opens the source filing in a new tab)

  5. Grant

    R01 · $752k · non-dilutive

    Mar 1, 1999

    CHILDREN'S HOSP OF PHILADELPHIA · PI BLOBEL, GERD A · NIDDK · award ends Mar 31, 2027 · Transcriptional Networks Controlling Erythroid Differentiation

    NIH RePORTER · NIH RePORTER 11323082 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources